Circadian rhythm of in vitro bone-resorbing activity in human serum

P. Lakatos, A. Blumsohn, R. Eastell, G. Tarjan, H. Shinoda, P. H. Stern

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Calciotropic hormones as well as biochemical parameters of bone formation and resorption show circadian rhythms. In a previous study in the rat, we observed a circadian rhythm in serum bone-resorbing activity (SBRA). In the present study, we investigated whether there was a circadian rhythm of SBRA in human serum. For this purpose, we studied 10 healthy premenopausal women and 5 healthy men. Blood was collected every 2 h, and urine samples were collected during 4-h periods for 24 h. For the determination of SBRA, media were prepared by reconstituting serum samples with Dulbecco's Modified Eagle's Medium at a ratio of 20% serum and 80% Dulbecco's Modified Eagle's Medium. Limb bones were dissected from 19-day old fetal rats prelabelled with 45Ca and were cultured for 72 h in the presence of the sera. Bone resorption was assessed from the 45Ca released into the culture medium and from that retained in the bone and was expressed as percentage 45Ca release. Serum calcium, phosphorus, PTH, cortisol, and urinary pyridinium cross-links were also determined. SBRA in human serum followed a circadian rhythm with a peak at about 0300 h and a nadir at 0700 h. There was no significant difference between the rhythm of SBRA of women and men. At concurrent time points, SBRA and serum PTH were positively correlated (r = 0.629; P <0.01), and SBRA and serum cortisol were negatively correlated (r = 0.797; P <0.01). To further investigate the possible contribution of these hormones to SBRA, either neutralizing anti-PTH antibody or RU-486 (mifepristone), a glucocorticoid receptor antagonist, was added to the serum samples of 6 subjects. Neutralizing the effect of PTH did not change the pattern of SBRA rhythm. The addition of RU-486 had a significant effect on the rhythm of SBRA, reducing the peak and nadir amplitudes. Thus we conclude that cortisol plays a major role in the rhythm of SBRA present in human serum; however, the influence of other factors cannot be excluded. Cortisol may be an important determinant of the circadian rhythm of bone resorption in vivo.

Original languageEnglish
Pages (from-to)3185-3190
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume80
Issue number11
Publication statusPublished - 1995

Fingerprint

Circadian Rhythm
Serum
Bone
Mifepristone
Hydrocortisone
Rats
Bone Resorption
bone resorption factor
In Vitro Techniques
Hormones
Eagles
Glucocorticoid Receptors
Phosphorus
Culture Media
Blood
Bone and Bones
Calcium
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Lakatos, P., Blumsohn, A., Eastell, R., Tarjan, G., Shinoda, H., & Stern, P. H. (1995). Circadian rhythm of in vitro bone-resorbing activity in human serum. Journal of Clinical Endocrinology and Metabolism, 80(11), 3185-3190.

Circadian rhythm of in vitro bone-resorbing activity in human serum. / Lakatos, P.; Blumsohn, A.; Eastell, R.; Tarjan, G.; Shinoda, H.; Stern, P. H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 80, No. 11, 1995, p. 3185-3190.

Research output: Contribution to journalArticle

Lakatos, P, Blumsohn, A, Eastell, R, Tarjan, G, Shinoda, H & Stern, PH 1995, 'Circadian rhythm of in vitro bone-resorbing activity in human serum', Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 11, pp. 3185-3190.
Lakatos, P. ; Blumsohn, A. ; Eastell, R. ; Tarjan, G. ; Shinoda, H. ; Stern, P. H. / Circadian rhythm of in vitro bone-resorbing activity in human serum. In: Journal of Clinical Endocrinology and Metabolism. 1995 ; Vol. 80, No. 11. pp. 3185-3190.
@article{bed1d0082187402389c3f561c4ce0ddc,
title = "Circadian rhythm of in vitro bone-resorbing activity in human serum",
abstract = "Calciotropic hormones as well as biochemical parameters of bone formation and resorption show circadian rhythms. In a previous study in the rat, we observed a circadian rhythm in serum bone-resorbing activity (SBRA). In the present study, we investigated whether there was a circadian rhythm of SBRA in human serum. For this purpose, we studied 10 healthy premenopausal women and 5 healthy men. Blood was collected every 2 h, and urine samples were collected during 4-h periods for 24 h. For the determination of SBRA, media were prepared by reconstituting serum samples with Dulbecco's Modified Eagle's Medium at a ratio of 20{\%} serum and 80{\%} Dulbecco's Modified Eagle's Medium. Limb bones were dissected from 19-day old fetal rats prelabelled with 45Ca and were cultured for 72 h in the presence of the sera. Bone resorption was assessed from the 45Ca released into the culture medium and from that retained in the bone and was expressed as percentage 45Ca release. Serum calcium, phosphorus, PTH, cortisol, and urinary pyridinium cross-links were also determined. SBRA in human serum followed a circadian rhythm with a peak at about 0300 h and a nadir at 0700 h. There was no significant difference between the rhythm of SBRA of women and men. At concurrent time points, SBRA and serum PTH were positively correlated (r = 0.629; P <0.01), and SBRA and serum cortisol were negatively correlated (r = 0.797; P <0.01). To further investigate the possible contribution of these hormones to SBRA, either neutralizing anti-PTH antibody or RU-486 (mifepristone), a glucocorticoid receptor antagonist, was added to the serum samples of 6 subjects. Neutralizing the effect of PTH did not change the pattern of SBRA rhythm. The addition of RU-486 had a significant effect on the rhythm of SBRA, reducing the peak and nadir amplitudes. Thus we conclude that cortisol plays a major role in the rhythm of SBRA present in human serum; however, the influence of other factors cannot be excluded. Cortisol may be an important determinant of the circadian rhythm of bone resorption in vivo.",
author = "P. Lakatos and A. Blumsohn and R. Eastell and G. Tarjan and H. Shinoda and Stern, {P. H.}",
year = "1995",
language = "English",
volume = "80",
pages = "3185--3190",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Circadian rhythm of in vitro bone-resorbing activity in human serum

AU - Lakatos, P.

AU - Blumsohn, A.

AU - Eastell, R.

AU - Tarjan, G.

AU - Shinoda, H.

AU - Stern, P. H.

PY - 1995

Y1 - 1995

N2 - Calciotropic hormones as well as biochemical parameters of bone formation and resorption show circadian rhythms. In a previous study in the rat, we observed a circadian rhythm in serum bone-resorbing activity (SBRA). In the present study, we investigated whether there was a circadian rhythm of SBRA in human serum. For this purpose, we studied 10 healthy premenopausal women and 5 healthy men. Blood was collected every 2 h, and urine samples were collected during 4-h periods for 24 h. For the determination of SBRA, media were prepared by reconstituting serum samples with Dulbecco's Modified Eagle's Medium at a ratio of 20% serum and 80% Dulbecco's Modified Eagle's Medium. Limb bones were dissected from 19-day old fetal rats prelabelled with 45Ca and were cultured for 72 h in the presence of the sera. Bone resorption was assessed from the 45Ca released into the culture medium and from that retained in the bone and was expressed as percentage 45Ca release. Serum calcium, phosphorus, PTH, cortisol, and urinary pyridinium cross-links were also determined. SBRA in human serum followed a circadian rhythm with a peak at about 0300 h and a nadir at 0700 h. There was no significant difference between the rhythm of SBRA of women and men. At concurrent time points, SBRA and serum PTH were positively correlated (r = 0.629; P <0.01), and SBRA and serum cortisol were negatively correlated (r = 0.797; P <0.01). To further investigate the possible contribution of these hormones to SBRA, either neutralizing anti-PTH antibody or RU-486 (mifepristone), a glucocorticoid receptor antagonist, was added to the serum samples of 6 subjects. Neutralizing the effect of PTH did not change the pattern of SBRA rhythm. The addition of RU-486 had a significant effect on the rhythm of SBRA, reducing the peak and nadir amplitudes. Thus we conclude that cortisol plays a major role in the rhythm of SBRA present in human serum; however, the influence of other factors cannot be excluded. Cortisol may be an important determinant of the circadian rhythm of bone resorption in vivo.

AB - Calciotropic hormones as well as biochemical parameters of bone formation and resorption show circadian rhythms. In a previous study in the rat, we observed a circadian rhythm in serum bone-resorbing activity (SBRA). In the present study, we investigated whether there was a circadian rhythm of SBRA in human serum. For this purpose, we studied 10 healthy premenopausal women and 5 healthy men. Blood was collected every 2 h, and urine samples were collected during 4-h periods for 24 h. For the determination of SBRA, media were prepared by reconstituting serum samples with Dulbecco's Modified Eagle's Medium at a ratio of 20% serum and 80% Dulbecco's Modified Eagle's Medium. Limb bones were dissected from 19-day old fetal rats prelabelled with 45Ca and were cultured for 72 h in the presence of the sera. Bone resorption was assessed from the 45Ca released into the culture medium and from that retained in the bone and was expressed as percentage 45Ca release. Serum calcium, phosphorus, PTH, cortisol, and urinary pyridinium cross-links were also determined. SBRA in human serum followed a circadian rhythm with a peak at about 0300 h and a nadir at 0700 h. There was no significant difference between the rhythm of SBRA of women and men. At concurrent time points, SBRA and serum PTH were positively correlated (r = 0.629; P <0.01), and SBRA and serum cortisol were negatively correlated (r = 0.797; P <0.01). To further investigate the possible contribution of these hormones to SBRA, either neutralizing anti-PTH antibody or RU-486 (mifepristone), a glucocorticoid receptor antagonist, was added to the serum samples of 6 subjects. Neutralizing the effect of PTH did not change the pattern of SBRA rhythm. The addition of RU-486 had a significant effect on the rhythm of SBRA, reducing the peak and nadir amplitudes. Thus we conclude that cortisol plays a major role in the rhythm of SBRA present in human serum; however, the influence of other factors cannot be excluded. Cortisol may be an important determinant of the circadian rhythm of bone resorption in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0028871975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028871975&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 3185

EP - 3190

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -